Published research describes suppression of NF-kappaB signaling, reduced production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), and modulation of the nitric oxide system (Catania et al., 2004)
Bypasses stomach acid and digestive enzymes
Future studies are required to clarify the limits of the redox window above which ROS become damaging, regulators of placental vascularization and angiogenesis, redox adaptation of the placenta to ensure positive pregnancy outcome, altered expression of antioxidant genes and underlying mechanisms through which OS affects pregnancy outcome
These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications